Research Article
Interleukin-6 and Interleukin-15 as Possible Biomarkers of the Risk of Autoimmune Diabetes Development
Table 2
Clinical and biochemical characteristics of the subgroups with T1D and LADA.
| | Type 1 diabetes (T1D) | LADA | Value |
| | N | 26 | 28 | | | Age (years) | 25.0 (18–34) | 39 (35–55) | <0.001 | | BMI (kg/m2) | 22.1 (17–33.2) | 23.5 (16.9–36) | 0.3 | | GADA (U/ml) | 109.4 (20–3971.1) | 139 (20.2–18792) | 0.4 | | IAA (U/ml) | 2.7 (1.3–7.6) | 2.6 (1.3–9.3) | 0.3 | | IA-2A (U/ml) | 14.1 (4.9–4000) | 5.6 (4.8–4000) | 0.01 | | eGDR (mg/kg/min) | 6.7 (2.6–11.7) | 6.2 (−0.7–10.28) | 1.00 | | HOMAIR | 2.9 (0.5–7.3) | 3.2 (0.5–8.5) | 0.2 | | IL-15 (pg/ml) | 1.5 (0.2–4.0) | 3.8 (1.7–7.0) | <0.001 | | IL-6 (pg/ml) | 25.0 (18–34) | 39 (35–55) | <0.001 |
|
|
Data are shown as medians (interquartile range).
|
